A record of what Morgan Stanley Analysis said publicly, with the source. Not advice.
“Maintains an 'underweight' rating on Cyient and trimmed its target price to ₹1,050, citing limited growth visibility in Q4FY25 and the absence of FY26 growth guidance. Lowered margin aspirations and delayed recovery timelines are key concerns, though the stock trades at relatively attractive valuations. The upcoming dividend policy review is also a factor to watch.”
Morgan Stanley Analysis’s track record (trackable calls only): 81 graded calls · 95% CI 31–52%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,050, as stated.
Window: 12 months, the default when no time frame is stated.
The target ₹1,050 was reached on a close. Hit.
The grader’s working: R4 TARGET_CALL: entered ₹1181.7 on 2025-04-28 (next trading session's close); target ₹1050 reached at close ₹1017 on 2026-02-12. Window 365 days — rule H3: a target call whose quote states no time frame is given 12 months, the broker convention.